Pharmacielo Ltd PCLOF

Primary Symbol: V.PCLO

PharmaCielo Ltd. is a Canada-based company with a focus on ethical and sustainable processing and supplying of all natural, pharmaceutical-grade medical cannabis products to channel distributors. The Company has two subsidiaries, PharmaCielo Colombia Holdings S.A.S. (PharmaCielo Colombia) and Ubiquo Telemedicina S.A.S. (Ubiquo). PharmaCielo Colombia cultivates and processes the Company’s all-natural cannabis into standardized, medicinal-grade oil extracts and related products. In Colombia, PharmaCielo Colombia is a licensed cultivator, producer, and distributor of both TetraHydroCannabinol (THC) and Cannabidiol (CBD) medical cannabis for use in Colombia, international export, and research purposes. Ubiquo is a knowledge management and medical consultation system that focuses on creating access to healthcare for Colombians. Ubiquo is a technology platform and a user interface that allows doctors and patients to communicate. Ubiquo is used as a communication tool.

TSXV:PCLO - Post by User

Pharmacielo Ltd

<< Previous

Bullboard Posts

Next >>

Post by mmaltaison Jun 15, 2023 8:49am

136 Views

Post# 35497677

insiders activities june 12th 2023

Amended Filing

As of 11:59pm ET June 15th, 2023

Filing Date	Transaction Date	Insider Name	Ownership Type	Securities	Nature of transaction	Volume or Value	Price
Jun 12/23	Jun 12/23	Petron, William Boris	Direct Ownership	Common Shares	57 - Exercise of rights	166,667	$0.480
Jun 12/23	Jun 12/23	Petron, William Boris	Direct Ownership	Restricted Share Units	57 - Exercise of rights	-166,667	$0.480
Jun 12/23	Jun 12/23	Lustig, Marc	Indirect Ownership	Debentures	16 - Acquisition under a prospectus exemption	$250,000
Jun 12/23	Jun 12/23	Lustig, Marc	Indirect Ownership	Debentures	16 - Acquisition under a prospectus exemption	$500,000
Jun 12/23	Jun 12/23	Lustig, Marc	Indirect Ownership	Warrants	16 - Acquisition under a prospectus exemption	62,500
Jun 12/23	Jun 12/23	Lustig, Marc	Indirect Ownership	Warrants	16 - Acquisition under a prospectus exemption	125,000
Apr 5/23	Mar 31/23	Lustig, Marc	Direct Ownership	Common Shares	11 - Acquisition carried out privately	466,504